Growth differentiation factor 15 (GDF15) predicts relapse free and overall survival in unresected locally advanced non-small cell lung cancer treated with chemoradiotherapy.

Saved in:
Bibliographic Details
Title: Growth differentiation factor 15 (GDF15) predicts relapse free and overall survival in unresected locally advanced non-small cell lung cancer treated with chemoradiotherapy.
Authors: Di Pastena, Fiorella1 (AUTHOR), Pond, Gregory2,3 (AUTHOR), Tsakiridis, Evangelia E.1 (AUTHOR), Gouveia, Andre2,4 (AUTHOR), Ahmadi, Elham1,2,5 (AUTHOR), Biziotis, Olga-Demetra1,2,5 (AUTHOR), Ali, Amr1,2,5 (AUTHOR), Swaminath, Anand2,4 (AUTHOR), Okawara, Gordon2,4 (AUTHOR), Ellis, Peter M.2 (AUTHOR), Abdulkarim, Bassam6 (AUTHOR), Ahmed, Naseer7 (AUTHOR), Robinson, Andrew8 (AUTHOR), Roa, Wilson9 (AUTHOR), Valdes, Mario10 (AUTHOR), Kavsak, Peter11 (AUTHOR), Wierzbicki, Marcin12 (AUTHOR), Wright, James2,3,4 (AUTHOR), Steinberg, Gregory1,13 (AUTHOR), Tsakiridis, Theodoros1,2,3,4,5 (AUTHOR) theos.tsakiridis@mcmaster.ca
Source: Radiation Oncology. 11/7/2024, Vol. 19 Issue 1, p1-9. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:1748717X
DOI:10.1186/s13014-024-02546-y